» Articles » PMID: 34345288

Overexpression of HOXD8 Inhibits the Proliferation, Migration and Invasion of Breast Cancer Cells by Downregulating ILP2 Expression

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 Aug 4
PMID 34345288
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is one of the most common malignant tumors in women. Although a number of homeobox (HOX) genes are known to serve an important role in breast cancer, the role of HOXD8 in breast cancer remains unclear. The aim of the present study was to investigate the role of HOXD8 in the physiological behaviors of breast cancer cells. The Gene Expression Profiling Interactive Analysis database was used to analyze the expression of HOXD8 in patients with breast cancer and in healthy subjects. Western blotting was performed to determine the expression levels of HOXD8 in several breast cancer cell lines; subsequently, HOXD8 expression was knocked down and overexpressed in MCF-7 cells. Cell Counting Kit-8, colony formation, wound healing and Transwell assays were used to evaluate the effects of HOXD8 on breast cancer cell viability, proliferation, migration and invasion, respectively. Chromatin immunoprecipitation and dual-luciferase reporter assays were conducted to identify the binding sites between HOXD8 and inhibitor of apoptosis-like protein-2 (ILP2). In addition, ILP2 expression levels were knocked down in MCF-7 cells. The results demonstrated that the expression levels of HOXD8 were significantly downregulated in breast cancer tissues and cell lines, and that the overexpression of HOXD8 inhibited the proliferation, invasion and migration of cancer cells. HOXD8 was shown to bind to the ILP2 promoter to regulate the expression of ILP2. Furthermore, ILP2 knockdown reversed the effects of HOXD8 knockdown on breast cancer cell proliferation, invasion and migration. In conclusion, the findings of the present study suggested that HOXD8 may inhibit the proliferation, migration and invasion of breast cancer cells by downregulating ILP2 expression.

Citing Articles

HOXB9 promotes laryngeal squamous cell carcinoma progression by upregulating MMP12.

Sun C, Deng H, Li Q, Wang P, Chen Y, Sun Y Funct Integr Genomics. 2024; 24(3):78.

PMID: 38632141 DOI: 10.1007/s10142-024-01357-4.


Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option.

Ding Y, Liu Q Front Cell Dev Biol. 2024; 12:1334417.

PMID: 38357002 PMC: 10864502. DOI: 10.3389/fcell.2024.1334417.


The diagnostic potential of miR-196a-1 in colorectal cancer.

Mehrjoei B, Haghnazari L, Bashiri H, Rezvani N BMC Cancer. 2024; 24(1):162.

PMID: 38302924 PMC: 10832129. DOI: 10.1186/s12885-024-11881-y.


LINC00969 inhibits proliferation with metastasis of breast cancer by regulating phosphorylation of PI3K/AKT and ILP2 expression through HOXD8.

Wen X, Hou Y, Zhou L, Fang X PeerJ. 2023; 11:e16679.

PMID: 38130932 PMC: 10734406. DOI: 10.7717/peerj.16679.


A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma.

Wang L, Wang X, Sun H, Wang W, Cao L Aging (Albany NY). 2023; 15(19):10746-10766.

PMID: 37827698 PMC: 10599751. DOI: 10.18632/aging.205116.


References
1.
Liu Y, Miao L, Ni R, Zhang H, Li L, Wang X . microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer. Oncol Rep. 2016; 36(6):3529-3535. DOI: 10.3892/or.2016.5149. View

2.
Kalhori V, Tornquist K . MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells. Mol Cell Endocrinol. 2015; 404:113-22. DOI: 10.1016/j.mce.2015.01.037. View

3.
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

4.
Zhao W, Geng D, Li S, Chen Z, Sun M . LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018; 7(3):842-855. PMC: 5852357. DOI: 10.1002/cam4.1353. View

5.
Xiang M, Zhou W, Gao D, Fang X, Liu Q . Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancer. Int J Mol Sci. 2012; 13(12):16737-50. PMC: 3546717. DOI: 10.3390/ijms131216737. View